483 Intergel Pharmaceuticals Feb 2014

483 Intergel Pharmaceuticals Feb 2014

Maria Estrella FDA, Nicholas Violand FDA$119.00 - Available Now

FDA investigators audited the Intergel Pharmaceuticals - Irvington, NJ, United States facility and issued 2 inspectional observations (via FDA 483) on 11 Feb 2014.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 11 Feb 2014
  • Location: Irvington, United States
  • FEI: 1000526797
Add To Cart